FR3107454B1 - Adjuvant de vaccin comprenant un microlatex inverse - Google Patents
Adjuvant de vaccin comprenant un microlatex inverse Download PDFInfo
- Publication number
- FR3107454B1 FR3107454B1 FR2001698A FR2001698A FR3107454B1 FR 3107454 B1 FR3107454 B1 FR 3107454B1 FR 2001698 A FR2001698 A FR 2001698A FR 2001698 A FR2001698 A FR 2001698A FR 3107454 B1 FR3107454 B1 FR 3107454B1
- Authority
- FR
- France
- Prior art keywords
- vaccine adjuvant
- reverse microlatex
- microlatex
- reverse
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012646 vaccine adjuvant Substances 0.000 title abstract 3
- 229940124931 vaccine adjuvant Drugs 0.000 title abstract 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal salts Chemical class 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 229920000058 polyacrylate Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Adjuvant de vaccin comprenant au moins un microlatex inverse, ledit microlatex inverse comprenant au moins une huile, au moins un agent tensio-actif, au moins un polymère comme par exemple un polyacrylate totalement ou partiellement neutralisé sous forme de sels de métaux alcalins ou de sel d’ammonium, ledit adjuvant de vaccin étant stérilisable dans son ensemble par filtration ou par passage à la chaleur d’un autoclave, et émulsionnable en une étape avec la phase aqueuse comprenant uniquement un antigène vaccinal.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2001698A FR3107454B1 (fr) | 2020-02-20 | 2020-02-20 | Adjuvant de vaccin comprenant un microlatex inverse |
EP21705950.0A EP4106723A1 (fr) | 2020-02-20 | 2021-02-17 | Adjuvant de vaccin comprenant un microlatex inverse |
US17/801,224 US20230052315A1 (en) | 2020-02-20 | 2021-02-17 | Vaccine adjuvant comprising an inverse microlatex |
KR1020227031834A KR20220143706A (ko) | 2020-02-20 | 2021-02-17 | 인버스 마이크로라텍스를 포함하는 백신 애주번트 |
MX2022010233A MX2022010233A (es) | 2020-02-20 | 2021-02-17 | Adyuvante de vacuna que comprende un microlatex inverso. |
PCT/EP2021/053873 WO2021165312A1 (fr) | 2020-02-20 | 2021-02-17 | Adjuvant de vaccin comprenant un microlatex inverse |
BR112022016519A BR112022016519A2 (pt) | 2020-02-20 | 2021-02-17 | Adjuvante de vacina que compreende um microlátex inverso |
CN202180016008.5A CN115151246A (zh) | 2020-02-20 | 2021-02-17 | 包含反相微胶乳的疫苗佐剂 |
JP2022549574A JP2023515028A (ja) | 2020-02-20 | 2021-02-17 | 逆マイクロラテックスを含むワクチンアジュバント |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2001698 | 2020-02-20 | ||
FR2001698A FR3107454B1 (fr) | 2020-02-20 | 2020-02-20 | Adjuvant de vaccin comprenant un microlatex inverse |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3107454A1 FR3107454A1 (fr) | 2021-08-27 |
FR3107454B1 true FR3107454B1 (fr) | 2023-02-10 |
Family
ID=71452368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2001698A Active FR3107454B1 (fr) | 2020-02-20 | 2020-02-20 | Adjuvant de vaccin comprenant un microlatex inverse |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230052315A1 (fr) |
EP (1) | EP4106723A1 (fr) |
JP (1) | JP2023515028A (fr) |
KR (1) | KR20220143706A (fr) |
CN (1) | CN115151246A (fr) |
BR (1) | BR112022016519A2 (fr) |
FR (1) | FR3107454B1 (fr) |
MX (1) | MX2022010233A (fr) |
WO (1) | WO2021165312A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114316132B (zh) * | 2022-01-28 | 2023-08-01 | 赛纳生物科技(北京)有限公司 | 一种乳液聚合合成功能性聚合物微球的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2798053A (en) | 1952-09-03 | 1957-07-02 | Goodrich Co B F | Carboxylic polymers |
US3919411A (en) | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
AU2021288A (en) | 1987-07-30 | 1989-02-09 | B.F. Goodrich Company, The | Solvent free acrylic acid type thickening agents and a method of making same |
US5288814A (en) | 1992-08-26 | 1994-02-22 | The B. F. Goodrich Company | Easy to disperse polycarboxylic acid thickeners |
FR2840909B1 (fr) | 2002-06-13 | 2005-01-28 | Seppic Sa | Nouveau microlatex inverse auto reversible, son procede de preparation et ses utilisations en cosmetique et dans l'industrie |
ES2572736T3 (es) | 2005-12-29 | 2016-06-02 | Boehringer Ingelheim Vetmedica, Inc. | Uso de una composición inmunógena para atenuar síntomas clínicos en cerdos |
FR2922767B1 (fr) | 2007-10-24 | 2009-12-18 | Seppic Sa | Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant. |
FR2957803B1 (fr) * | 2010-03-24 | 2012-06-01 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Diluants adjuvants de vaccins vivants pour maladies porcines |
FR3026012B1 (fr) * | 2014-09-23 | 2017-12-01 | Soc D'exploitation De Produits Pour Les Industries Chimiques Seppic | Administration par voie orale d'au moins une substance active pharmaceutique et/ou antigenique |
-
2020
- 2020-02-20 FR FR2001698A patent/FR3107454B1/fr active Active
-
2021
- 2021-02-17 KR KR1020227031834A patent/KR20220143706A/ko active Search and Examination
- 2021-02-17 CN CN202180016008.5A patent/CN115151246A/zh active Pending
- 2021-02-17 WO PCT/EP2021/053873 patent/WO2021165312A1/fr unknown
- 2021-02-17 EP EP21705950.0A patent/EP4106723A1/fr active Pending
- 2021-02-17 BR BR112022016519A patent/BR112022016519A2/pt unknown
- 2021-02-17 JP JP2022549574A patent/JP2023515028A/ja active Pending
- 2021-02-17 MX MX2022010233A patent/MX2022010233A/es unknown
- 2021-02-17 US US17/801,224 patent/US20230052315A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4106723A1 (fr) | 2022-12-28 |
JP2023515028A (ja) | 2023-04-12 |
WO2021165312A1 (fr) | 2021-08-26 |
MX2022010233A (es) | 2023-01-18 |
CN115151246A (zh) | 2022-10-04 |
BR112022016519A2 (pt) | 2022-10-11 |
FR3107454A1 (fr) | 2021-08-27 |
US20230052315A1 (en) | 2023-02-16 |
KR20220143706A (ko) | 2022-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR3107454B1 (fr) | Adjuvant de vaccin comprenant un microlatex inverse | |
BR112018003224A2 (pt) | remoção de uma cápsula de um suporte de cápsula | |
WO2009144402A3 (fr) | Installation pour la production de froid, de chaleur et/ou de travail | |
EP2711499A8 (fr) | Moteur à pistons axiaux | |
AR090348A1 (es) | Catalizador, proceso para la preparacion de dicho catalizador y uso de dicho catalizador en un proceso y en un dispositivo para la preparacion de olefinas | |
FR3061905B1 (fr) | Composition comprenant du 2,3,3,3-tetrafluoropropene | |
FR3061906B1 (fr) | Composition comprenant du 2,3,3,3-tetrafluoropropene | |
NZ568210A (en) | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines | |
CU23790A3 (es) | Sistema de ablación de placas guiadas por imágenes | |
SA521421969B1 (ar) | مكابس لاستخدامها فى أجهزة تبادل الموائع وأجهزة و أنظمة وطرق متعلقة بها | |
EP2518283A3 (fr) | Système de refroidissement de générateur intégré | |
BR112022015428A2 (pt) | Conjunto de plataformas de filtro de tambor giratório compreendendo uma presilha | |
BR112015005493A2 (pt) | conjunto de forquilha de direção | |
EP2423472A3 (fr) | Système et procédé de cycle de Rankine organique | |
RU2016103031A (ru) | Применение высокоэффективных рабочих сред для тепловых двигателей | |
AR122188A1 (es) | Máquina de estampación de accesorios de tubería de carrera de avance, sistemas y métodos | |
EP2993426A3 (fr) | Cycles de pompe à chaleur entraînée remplaçable | |
BR112019023602A2 (pt) | Dispositivos, sistemas e métodos relativos a dispositivos de comunicação de mão para diferenciação in situ entre infecções virais e não virais | |
FR3056909B1 (fr) | Composition comprenant au moins un sel pharmaceutiquement acceptable d'elafibranor soluble en milieux aqueux presentant une absorption intestinale amelioree | |
EA201690895A1 (ru) | Офтальмологический раствор тартрата бримонидина для местного применения | |
FR3073859B1 (fr) | Agent tensioactif autoportant pour la stimulation des puits | |
MA42290B1 (fr) | Gel fluide ophtalmique de bimatoprost | |
CO5660272A2 (es) | Vacunas bovinas con adyuvantes | |
BR112022008826A2 (pt) | Junta universal com rigidez aprimorada | |
CL2020002434A1 (es) | Formulación para emulsión bituminosa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20210827 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |